CHICAGO, IL, USA I June 2, 2025 I ImmuneOncia Therapeutics, Inc. (CEO Heung-Tae Kim) announced interim results today from the ongoing Phase 1b clinical trial ...

Liver cancer is a lethal disease with limited treatment options for advanced stages. While risk factors such as viral ...

While oesophageal cancer data by histology were relatively complete, it represented a clear challenge for stomach cancer, where on average 49% of all cancers were categorised as overlapping or ...

Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related deaths worldwide due to lack of effective diagnosis at early stages and limited comprehension of its pathogenesis, thus ...